Articles:
Publications:

4 hours ago

Lonza, Engitix Ink ADC Licensing Deal

Lonza, Engitix Ink ADC Licensing Deal

Editor’s Take: Engitix is the latest company to tap Lonza’s platform to support the development of ADC therapies. Stipple Bio and InduPro entered similar licensing agreements earlier this year. Lonza, a leading contract development and... Read more.

More from Contract Pharma

Contract Pharma an hour ago
Turn on Transparency.
Wheeler Bio Welcomes Rajesh Beri as New Chief Development Officer
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
Contract Pharma an hour ago
Turn on Transparency.
Forge Biologics Launches AAV Development, cGMP Manufacturing Partnership with Restore Vision
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
Contract Pharma an hour ago
Turn on Transparency.
From Potential to Practical at DIA 2026: Building Trust in AI at Scale
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

9 hours ago
20 Countries Move to Ban Social Media for Children as Global Crackdown Grow
Neutral | Owner: Vitaliy Laptenok
9 hours ago
Russia Launches New Wave of Disinformation Against Residents of Sumy Region on TikTok
Public Broadcaster | Owner: Ukrainian Government
9 hours ago
Paramount and Warner Bros Mega Merger Paused by Judge
Public Broadcaster | Owner: British Government

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more